期刊
FUTURE ONCOLOGY
卷 16, 期 5, 页码 75-80出版社
FUTURE MEDICINE LTD
DOI: 10.2217/fon-2019-0745
关键词
BRCA1; BRCA2; defective DNA repair; immunotherapy; PARP inhibitors; prostate cancer